The Journal of Immunology, Vol 155, Issue 2 748-758, Copyright © 1995 by American Association of Immunologists

ARTICLES

Immunization with a single T helper cell epitope abrogates Friend virus- induced early erythroid proliferation and prevents late leukemia development

M Miyazawa, R Fujisawa, C Ishihara, YA Takei, T Shimizu, H Uenishi, H Yamagishi and K Kuribayashi
Department of Pathology, Tohoku University School of Medicine, Sendai, Japan.

Synthetic peptide vaccines containing a single Th cell epitope identified in the gp70 envelope glycoprotein of Friend murine leukemia helper virus induced potent protective immunity against Friend virus infection. H-2a/b mice immunized by a single s.c. injection of the CFA emulsion containing a peptide that represented the N-terminal gp70 epitope recovered slowly from initial development of splenomegaly, and most did not develop late leukemia, whereas most of the control mice given an injection of CFA alone showed sustained leukemic splenomegaly after the challenge with Friend virus. The mice of the same genetic background immunized with the C-terminal Th cell epitope by a single injection of a separate synthetic peptide eliminated virus-producing cells from the spleen within 12 days after inoculation of Friend virus complex, and did not develop early splenomegaly or polycythemia. H-2a/a mice were not protected by immunization with either one of the two synthetic peptides. Earlier production and more rapid class switching of virus-neutralizing Abs were observed in H-2a/b mice immunized with the peptide vaccines after the challenge with Friend virus, compared with the responses of the control mice. Detailed kinetic and immunohistopathologic analyses suggested that Th cells might be directly involved in the growth inhibition and elimination of virus- infected erythroid precursor cells.

This article has been cited by other articles:

				S. Caserta, P. Alessi, J. Guarnerio, V. Basso, and A. Mondino Synthetic CD4+ T Cell-Targeted Antigen-Presenting Cells Elicit Protective Antitumor Responses Cancer Res., April 15, 2008; 68(8): 3010 - 3018. [Abstract] [Full Text] [PDF]

				V. S. Zimmermann, A. Casati, C. Schiering, S. Caserta, R. Hess Michelini, V. Basso, and A. Mondino Tumors Hamper the Immunogenic Competence of CD4+ T Cell-Directed Dendritic Cell Vaccination J. Immunol., September 1, 2007; 179(5): 2899 - 2909. [Abstract] [Full Text] [PDF]

				H. Kawabata, A. Niwa, S. Tsuji-Kawahara, H. Uenishi, N. Iwanami, H. Matsukuma, H. Abe, N. Tabata, H. Matsumura, and M. Miyazawa Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease Int. Immunol., January 1, 2006; 18(1): 183 - 198. [Abstract] [Full Text] [PDF]

				D. Sugahara, S. Tsuji-Kawahara, and M. Miyazawa Identification of a Protective CD4+ T-Cell Epitope in p15gag of Friend Murine Leukemia Virus and Role of the MA Protein Targeting the Plasma Membrane in Immunogenicity J. Virol., June 15, 2004; 78(12): 6322 - 6334. [Abstract] [Full Text] [PDF]

				N. Iwanami, A. Niwa, Y. Yasutomi, N. Tabata, and M. Miyazawa Role of Natural Killer Cells in Resistance against Friend Retrovirus-Induced Leukemia J. Virol., April 1, 2001; 75(7): 3152 - 3163. [Abstract] [Full Text]

				J. van Bergen, M. Camps, R. Offringa, C. J. M. Melief, F. Ossendorp, and F. Koning Superior Tumor Protection Induced by a Cellular Vaccine Carrying a Tumor-specific T Helper Epitope by Genetic Exchange of the Class II-associated Invariant Chain Peptide Cancer Res., November 1, 2000; 60(22): 6427 - 6433. [Abstract] [Full Text]

				K. J. Hasenkrug Lymphocyte Deficiencies Increase Susceptibility to Friend Virus-Induced Erythroleukemia in Fv-2 Genetically Resistant Mice J. Virol., August 1, 1999; 73(8): 6468 - 6473. [Abstract] [Full Text]

				U. Dittmer, D. M. Brooks, and K. J. Hasenkrug Characterization of a Live-Attenuated Retroviral Vaccine Demonstrates Protection via Immune Mechanisms J. Virol., August 1, 1998; 72(8): 6554 - 6558. [Abstract] [Full Text] [PDF]

				R. E. M. Toes, E. I. H. van der Voort, S. P. Schoenberger, J. W. Drijfhout, L. van Bloois, G. Storm, W. M. Kast, R. Offringa, and C. J. M. Melief Enhancement of Tumor Outgrowth Through CTL Tolerization After Peptide Vaccination Is Avoided by Peptide Presentation on Dendritic Cells J. Immunol., May 1, 1998; 160(9): 4449 - 4456. [Abstract] [Full Text] [PDF]

				F. Ossendorp, E. Mengede, M. Camps, R. Filius, and C. J.M. Melief Specific T Helper Cell Requirement for Optimal Induction of Cytotoxic T Lymphocytes against Major Histocompatibility Complex Class II Negative Tumors J. Exp. Med., March 2, 1998; 187(5): 693 - 702. [Abstract] [Full Text] [PDF]

				K. J. Hasenkrug and B. Chesebro Immunity to retroviral infection: The Friend virus model PNAS, July 22, 1997; 94(15): 7811 - 7816. [Abstract] [Full Text] [PDF]